Domains targeting keyword 'involuntary treatment'

The mission of the DMRF is to advance research for more dystonia treatments and a cure, promote awareness, and support the well being of affected individuals and families.

Learn more about INGREZZA—the first FDA-approved treatment for adults with tardive dyskinesia (TD).

Get information on INGREZZA safety, dosing, and efficacy to help support your adult patients with TD. See safety and product information.

Blepharospasm is a condition in which there is sustained, forced, involuntary closing of the eyelids. Symptoms, cause and treatment are discussed.

Iranian researchers introduce definitive treatment of stuttering

The Treatment Advocacy Center is a national nonprofit organization dedicated to making treatment possible for severe mental illness. The organization promotes laws, policies and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.